UnitedHealth (UNH) shares lost as much as 7% this morning following allegations the insurance giant secretly paid thousands ...

UNH stock rebounds but faces DOJ probe, CEO exit, and weak techs. Is this a dead cat bounce or start of more pain? Bear call ...

The allegations, part of a series of cost-cutting tactics, add to the litany of negatives that have hurt UnitedHealth in the last several months.

Real-time index price for TSX Composite Index (TXCX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

UnitedHealth Group has been a reliable megacap for years. Its sudden decline in recent months is raising questions about the future fate of its stock.

Moreover, the UnitedHealth stock is at the moment trading below both the short-term 50-day moving average (DMA) and long-term 200-DMA, indicating a bearish trend. This suggests that it’s wise to avoid ...

UNH's dip to $250 offers a strong buy opportunity with solid revenue growth, resilient dividends, and historic low P/E.

UnitedHealth volatility highlights a key difference between the Dow and the S&P 500. UnitedHealth’s sharp decline and ...

The DOJ's criminal healthcare fraud unit is reportedly examining UnitedHealth's Medicare Advantage business practices.

• First Solar has a price-to-sales (P/S) ratio of 3.5 compared to a figure of 2.8 for the S&P 500 • Moreover, the company’s ...